Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan

Meng Shiuan Hsu, Jann Tay Wang, Wen Kuei Huang, Yung Ching Liu, Shan Chwen Chang

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background and Purpose: Although the clinical manifestations of and risk factors for Clostridium difficile-associated diarrhea (CDAD) have been extensively investigated in western populations, data from Taiwanese patients are comparatively limited. This study investigated the incidence density of CDAD in Taiwanese patients and also the risk factors and clinical manifestations of CDAD. Methods: From September 21, 2003 to December 21, 2003, patients hospitalized in 2 infection wards and 6 medical intensive care units at National Taiwan University Hospital who were older than 20 years, had a history of antibiotic usage within the prior 6 weeks, and developed diarrhea without another identified etiology were classified as having antibiotic-associated diarrhea (AAD), and were enrolled for further study. The diagnosis of CDAD was established when toxin A of C. difficile was detected in stool. Results: The incidence density of AAD was 1/100 person-days of antibiotics usage. CDAD accounted for 12.5% of AAD. Fever and abdominal discomfort developed in only less than half of CDAD patients. Pus cell in the stool sample was found in 100 percent of patients with CDAD. Univariate analysis revealed that presence of malignancy and treatment with antifungal agents within the previous 6 weeks were risk factors for CDAD development. In multivariate analysis, use of antifungal agents was the only independent risk factor for CDAD. Conclusion: The incidence density of CDAD in this study of Taiwanese patients with AAD was 12.5%. Prior usage of antifungal agents was the only independent factor associated with subsequent CDAD development in patients with AAD.

Original languageEnglish
Pages (from-to)242-248
Number of pages7
JournalJournal of Microbiology, Immunology and Infection
Volume39
Issue number3
Publication statusPublished - Jun 2006
Externally publishedYes

Fingerprint

Clostridium difficile
Taiwan
Tertiary Care Centers
Diarrhea
Anti-Bacterial Agents
Antifungal Agents
Suppuration
Incidence

Keywords

  • Antibacterial agents
  • Clostridium difficile
  • Diarrhea
  • Prevalence
  • Risk factors
  • Taiwan

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Allergy
  • Immunology and Microbiology(all)

Cite this

Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan. / Hsu, Meng Shiuan; Wang, Jann Tay; Huang, Wen Kuei; Liu, Yung Ching; Chang, Shan Chwen.

In: Journal of Microbiology, Immunology and Infection, Vol. 39, No. 3, 06.2006, p. 242-248.

Research output: Contribution to journalArticle

@article{517e74ceaa7e4ef59a102505ed89a0d2,
title = "Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan",
abstract = "Background and Purpose: Although the clinical manifestations of and risk factors for Clostridium difficile-associated diarrhea (CDAD) have been extensively investigated in western populations, data from Taiwanese patients are comparatively limited. This study investigated the incidence density of CDAD in Taiwanese patients and also the risk factors and clinical manifestations of CDAD. Methods: From September 21, 2003 to December 21, 2003, patients hospitalized in 2 infection wards and 6 medical intensive care units at National Taiwan University Hospital who were older than 20 years, had a history of antibiotic usage within the prior 6 weeks, and developed diarrhea without another identified etiology were classified as having antibiotic-associated diarrhea (AAD), and were enrolled for further study. The diagnosis of CDAD was established when toxin A of C. difficile was detected in stool. Results: The incidence density of AAD was 1/100 person-days of antibiotics usage. CDAD accounted for 12.5{\%} of AAD. Fever and abdominal discomfort developed in only less than half of CDAD patients. Pus cell in the stool sample was found in 100 percent of patients with CDAD. Univariate analysis revealed that presence of malignancy and treatment with antifungal agents within the previous 6 weeks were risk factors for CDAD development. In multivariate analysis, use of antifungal agents was the only independent risk factor for CDAD. Conclusion: The incidence density of CDAD in this study of Taiwanese patients with AAD was 12.5{\%}. Prior usage of antifungal agents was the only independent factor associated with subsequent CDAD development in patients with AAD.",
keywords = "Antibacterial agents, Clostridium difficile, Diarrhea, Prevalence, Risk factors, Taiwan",
author = "Hsu, {Meng Shiuan} and Wang, {Jann Tay} and Huang, {Wen Kuei} and Liu, {Yung Ching} and Chang, {Shan Chwen}",
year = "2006",
month = "6",
language = "English",
volume = "39",
pages = "242--248",
journal = "Journal of Microbiology, Immunology and Infection",
issn = "0253-2662",
publisher = "Elsevier Taiwan LLC",
number = "3",

}

TY - JOUR

T1 - Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan

AU - Hsu, Meng Shiuan

AU - Wang, Jann Tay

AU - Huang, Wen Kuei

AU - Liu, Yung Ching

AU - Chang, Shan Chwen

PY - 2006/6

Y1 - 2006/6

N2 - Background and Purpose: Although the clinical manifestations of and risk factors for Clostridium difficile-associated diarrhea (CDAD) have been extensively investigated in western populations, data from Taiwanese patients are comparatively limited. This study investigated the incidence density of CDAD in Taiwanese patients and also the risk factors and clinical manifestations of CDAD. Methods: From September 21, 2003 to December 21, 2003, patients hospitalized in 2 infection wards and 6 medical intensive care units at National Taiwan University Hospital who were older than 20 years, had a history of antibiotic usage within the prior 6 weeks, and developed diarrhea without another identified etiology were classified as having antibiotic-associated diarrhea (AAD), and were enrolled for further study. The diagnosis of CDAD was established when toxin A of C. difficile was detected in stool. Results: The incidence density of AAD was 1/100 person-days of antibiotics usage. CDAD accounted for 12.5% of AAD. Fever and abdominal discomfort developed in only less than half of CDAD patients. Pus cell in the stool sample was found in 100 percent of patients with CDAD. Univariate analysis revealed that presence of malignancy and treatment with antifungal agents within the previous 6 weeks were risk factors for CDAD development. In multivariate analysis, use of antifungal agents was the only independent risk factor for CDAD. Conclusion: The incidence density of CDAD in this study of Taiwanese patients with AAD was 12.5%. Prior usage of antifungal agents was the only independent factor associated with subsequent CDAD development in patients with AAD.

AB - Background and Purpose: Although the clinical manifestations of and risk factors for Clostridium difficile-associated diarrhea (CDAD) have been extensively investigated in western populations, data from Taiwanese patients are comparatively limited. This study investigated the incidence density of CDAD in Taiwanese patients and also the risk factors and clinical manifestations of CDAD. Methods: From September 21, 2003 to December 21, 2003, patients hospitalized in 2 infection wards and 6 medical intensive care units at National Taiwan University Hospital who were older than 20 years, had a history of antibiotic usage within the prior 6 weeks, and developed diarrhea without another identified etiology were classified as having antibiotic-associated diarrhea (AAD), and were enrolled for further study. The diagnosis of CDAD was established when toxin A of C. difficile was detected in stool. Results: The incidence density of AAD was 1/100 person-days of antibiotics usage. CDAD accounted for 12.5% of AAD. Fever and abdominal discomfort developed in only less than half of CDAD patients. Pus cell in the stool sample was found in 100 percent of patients with CDAD. Univariate analysis revealed that presence of malignancy and treatment with antifungal agents within the previous 6 weeks were risk factors for CDAD development. In multivariate analysis, use of antifungal agents was the only independent risk factor for CDAD. Conclusion: The incidence density of CDAD in this study of Taiwanese patients with AAD was 12.5%. Prior usage of antifungal agents was the only independent factor associated with subsequent CDAD development in patients with AAD.

KW - Antibacterial agents

KW - Clostridium difficile

KW - Diarrhea

KW - Prevalence

KW - Risk factors

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=33748639961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748639961&partnerID=8YFLogxK

M3 - Article

VL - 39

SP - 242

EP - 248

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

SN - 0253-2662

IS - 3

ER -